OVERVIEW
The market for active implantable medical devices is forecast to reach USD 27.43 billion by 2024, increasing the forecast period at a CAGR of 6.9%. The rising aging population, increasing cardiovascular and neurological disease prevalence, expanded neurostimulator applications, and favorable reimbursement scenario for ENT procedures are some of the factors that drive this market’s growth.









TABLE OF CONTENT
1 Global Active Implantable Medical Devices Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Active Implantable Medical Devices Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Active Implantable Medical Devices Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Active Implantable Medical Devices Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Active Implantable Medical Devices Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Active Implantable Medical Devices Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Active Implantable Medical Devices Market – By Product (Market Size – &
million/billion)
8.1 Implantable Cardioverter Defibrillators
8.2 Ventricular Assist Devices
8.3 Implantable Heart Monitors/Insertable Loop Recorders
8.4 Neurostimulators
8.5 Implantable Hearing Devices
9 Global Active Implantable Medical Devices Market – By Delivery Model
9.1 Subscription
9.2 Ownership
10 Global Active Implantable Medical Devices Market – By Function
10.1 Clinical Functionality
10.2 Administrative Functionality
10.3 Financial Functionality
11 Global Active Implantable Medical Devices Market – By End-User
11.1 Providers
11.1.1 Community Clinics
11.1.2 Hospitals
11.1.3 Private Practices
11.2 Payers
11.3 Patients
12 Global Active Implantable Medical Devices Market – By Geography (Market Size – &
million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa
13 Global Active Implantable Medical Devices Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships
14 Global Active Implantable Medical Devices Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Abbott Laboratories
14.3 Medtronic PLC
14.4 Boston Scientific Corporation
14.5 Biotronik Se & Co., Kg
14.6 Med-EL
14.7 Nurotron Biotechnology Co. Ltd.
14.8 Livanova PLC
14.9 William Demant Holding A/S
14.10 Cochlear Limited
14.11 Sonova Holding AG
14.12 Company 11 & more
15 Global Active Implantable Medical Devices Market – Appendix
15.1 Sources
15.2 Abbreviations